Syngene International Ltd. - Research Center
539268 SYNGENE Group (A) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 20 | Mar ' 19 | Mar ' 18 | Mar ' 17 | Mar ' 16 | |
|---|---|---|---|---|---|
| Sales | 2,011.90 | 1,825.60 | 1,423.10 | 1,200.90 | 1,107.00 |
| Operating profit | 616.70 | 535.60 | 464.40 | 407.60 | 357.80 |
| Interest | 34.60 | 32.30 | 22.70 | 17.50 | 8.40 |
| Gross profit | 663.70 | 578.40 | 503.50 | 460.80 | 355.50 |
| EPS (Rs) | 10.29 | 16.54 | 15.26 | 14.37 | 11.10 |
Annual
results in details
| Mar ' 20 | Mar ' 19 | Mar ' 18 | Mar ' 17 | Mar ' 16 | |
|---|---|---|---|---|---|
| Other income | 81.60 | 75.10 | 61.80 | 70.70 | 6.10 |
| Stock adjustment | 0.80 | 26.00 | -13.50 | 0.60 | -4.40 |
| Raw material | 518.60 | 505.30 | 395.20 | 321.20 | 314.80 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 572.20 | 465.40 | 376.90 | 308.60 | 250.30 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 303.60 | 293.30 | 200.10 | 162.90 | 188.50 |
| Provisions made | - | - | - | - | - |
| Depreciation | 219.30 | 164.20 | 131.40 | 114.30 | 97.30 |
| Taxation | 104.20 | 83.50 | 67.00 | 59.20 | 37.00 |
| Net profit / loss | 411.50 | 330.70 | 305.10 | 287.30 | 221.20 |
| Extra ordinary item | 71.30 | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 400.00 | 200.00 | 200.00 | 200.00 | 199.20 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 30.65 | 29.34 | 32.63 | 33.94 | 32.32 |
| GPM (%) | 31.70 | 30.43 | 33.91 | 36.24 | 31.94 |
| NPM (%) | 19.66 | 17.40 | 20.55 | 22.59 | 19.87 |
Mutual Fund Selector
Find the fund that is right for you
© 2020 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis